Imagion Biosystems has announced the successful completion of the renounceable rights issue raising approximately $3.6 million.
Read Imagion Biosystems’ Right Issue raises $3.6 million.
Dr. Nina Webster Joins IBX Board of Directors
September 1, 2025
Imagion Biosystems (ASX: IBX) (Company or Imagion), a company dedicated to improving healthcare outcomes through the early detection of cancer utilizing its proprietary MagSense® imaging